arrow
S

Stefan Slamanig

ica hn school of medicine at mount sinai
H指数:11
被引数:656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters

同源和异源NDV和MVA SARS-CoV-2疫苗在小鼠和沙鼠中的免疫原性和效力

2025-11-210
OAAI
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination

接种KP.2单价mRNA疫苗后,对SARS-CoV-2变异株LP.8.1、LF.7.1、NB.1.8.1、XFG和BA.3.2的抗体应答

MBIO
IF4.7
2025-11-012
PRE
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models

基于NDV的多价黏膜疫苗在动物模型中提供针对SARS-CoV-2变体的交叉反应性免疫应答

2025-03-170
OA
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
2025-01-030
PRE
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach

基于镶嵌血凝素方法的通用乙型流感灭活疫苗的临床前评估

2024-11-170
OAAI
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
2023-02-158
OA
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
2022-03-0127
OAAI
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
2021-10-2757
OAAI